Purchase Order 75N98026P01205

The National Heart Lung and Blood Institute awarded a $19,006.85 firm fixed-price purchase order to the University of Illinois for in vivo drug study research to support a Bench to Bedside and Back collaboration. The contract, which commenced on September 1, 2025, with an ultimate completion date of August 31, 2026, will be performed at the university's Urbana, Illinois location. This award represents support for the Pulmonary Vascular Biology Lab's research initiatives and was not set aside for...

<p>The National Heart Lung and Blood Institute awarded a purchase order to the University of Chicago for $31,999.79 on December 15, 2016, to provide scientific support services to the NHLBI Division of Intramural Research. The order is firm fixed price with no set-aside designation. Work is performed in Chicago, Illinois. The period of performance is one year, with ultimate completion on December 14, 2017.</p>

The National Heart, Lung, and Blood Institute (NHLBI) awarded a $19,468.53 firm fixed-price purchase order to the University of Illinois (Board of Trustees of the University of Illinois) on September 1, 2025, for in vivo drug study work to support the Pulmonary Vascular Biology Lab. This contract, which carries an ultimate completion date of August 31, 2026, is part of a collaborative research initiative under the Bench to Bedside and Back Award program, a translational research framework...

<p>The National Heart Lung and Blood Institute awarded a purchase order to The Washington University for $4,446.00 on September 14, 2011, for other special studies and analyses. Place of performance is University City, Missouri. The order carries a firm fixed price structure and ultimate completion date of December 23, 2012.</p>

This federal contract award to the University of Illinois, doing business as The Board of Trustees of the University of Illinois, was issued by the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), a civilian agency. The $633,029.25 cost-no-fee definitive contract is for biomedical research and exploratory work, with a completion date of June 3, 2013. The University of Illinois has extensive experience as both a prime contractor and subcontractor...

<p>The National Heart Lung and Blood Institute issued a purchase order to New York University School of Medicine valued at $11,864.00, awarded on March 7, 2018, with ultimate completion on March 14, 2019. The order is a firm fixed-price acquisition with no set-aside. Performance takes place in New York, NY. The source does not specify the goods or services procured.</p>

<p>The National Heart Lung and Blood Institute awarded a firm fixed price purchase order to University of Maryland, Baltimore for multi-scale phenotyping of heart failure with a ceiling value of $702,063.57 and an award date of June 16, 2025. Work is performed in Baltimore, Maryland, with an ultimate completion date of September 15, 2030. The purchase order calls for advanced biomedical research services supporting the Institute's cardiovascular research mission.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to the University of Chicago for $24,790.94 on March 1, 2021. The Department of Chemistry at the University of Chicago provides professional services to assist the Laboratory of Computational Biology with revision of the CHARMM polarizable (Drude) lipid force field. Work is performed in Chicago, Illinois. The order is firm fixed price with an ultimate completion date of November 30, 2021.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Inova Health Care Services for graft sample and data collection services, valued at $348,840, with an award date of September 18, 2026 and an ultimate completion date of September 17, 2030. Work is performed in Bethesda, Maryland. The order is firm fixed price with no set-aside category applied.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to the University of Chicago for a Comprehensive IBMF Sequencing Panel valued at $48,000 on August 13, 2019, with completion by August 12, 2020. Work is performed in Chicago, Illinois. This firm fixed price purchase order procures sequencing panel services for biomedical research.</p>